34.73
Twist Bioscience Corp stock is traded at $34.73, with a volume of 1.26M.
It is up +0.12% in the last 24 hours and down -3.34% over the past month.
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
See More
Previous Close:
$34.69
Open:
$34.89
24h Volume:
1.26M
Relative Volume:
1.17
Market Cap:
$2.08B
Revenue:
$277.49M
Net Income/Loss:
$-192.14M
P/E Ratio:
-10.34
EPS:
-3.36
Net Cash Flow:
$-95.52M
1W Performance:
-3.61%
1M Performance:
-3.34%
6M Performance:
-32.09%
1Y Performance:
-37.84%
Twist Bioscience Corp Stock (TWST) Company Profile
Name
Twist Bioscience Corp
Sector
Industry
Phone
800-719-0671
Address
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Compare TWST with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
TWST
Twist Bioscience Corp
|
34.73 | 2.08B | 277.49M | -192.14M | -95.52M | -3.36 |
![]()
TMO
Thermo Fisher Scientific Inc
|
477.28 | 182.01B | 43.21B | 6.58B | 6.17B | 17.29 |
![]()
DHR
Danaher Corp
|
203.99 | 148.12B | 24.01B | 3.41B | 4.86B | 4.70 |
![]()
IDXX
Idexx Laboratories Inc
|
572.09 | 46.09B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
A
Agilent Technologies Inc
|
118.05 | 34.04B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
191.54 | 33.07B | 15.50B | 1.33B | 2.16B | 7.34 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-13-24 | Initiated | Wolfe Research | Outperform |
Jun-04-24 | Initiated | Guggenheim | Buy |
Jan-17-24 | Upgrade | Goldman | Neutral → Buy |
Sep-27-23 | Initiated | Berenberg | Buy |
Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
Jan-03-23 | Upgrade | Evercore ISI | In-line → Outperform |
Mar-02-22 | Resumed | Cowen | Outperform |
Oct-15-21 | Resumed | Cowen | Outperform |
Jun-29-21 | Initiated | William Blair | Outperform |
Jun-04-21 | Initiated | Goldman | Neutral |
Apr-12-21 | Initiated | Piper Sandler | Overweight |
Feb-05-21 | Downgrade | JP Morgan | Neutral → Underweight |
Jan-04-21 | Downgrade | Evercore ISI | Outperform → In-line |
Oct-20-20 | Initiated | SVB Leerink | Mkt Perform |
May-31-19 | Initiated | Evercore ISI | Outperform |
Nov-26-18 | Initiated | JP Morgan | Neutral |
View All
Twist Bioscience Corp Stock (TWST) Latest News
What risks could impact Twist Bioscience Corporation stock performanceWatchlist Generator for Smart Money Signals - Newser
Using fundamentals and technicals on Twist Bioscience CorporationAsset Allocation Summary With Future Outlook - Newser
Global Antibody Discovery Market to Observe Stupendous Growth at a CAGR of ~10% by 2032 | DelveInsight - GlobeNewswire Inc.
Will Twist Bioscience Corporation benefit from macro trendsAI Powered Stock Market Trend Forecast - Newser
Is Twist Bioscience Corp. (TWST) Nearing Profitability? - MSN
Why Twist Bioscience Corporation stock attracts strong analyst attentionAsset Allocation Summary With Future Outlook - Newser
Volume spikes in Twist Bioscience Corporation stock – what they meanFree Real Trader Watchlist of Hot Stocks - Newser
How Resilient Is Twist Bioscience Corporation Stock During Economic DownturnsDay Trading Setup Forecast with Trend Model - Newser
Should I hold or sell Twist Bioscience Corporation stock in 2025Build your wealth with consistent stock growth - jammulinksnews.com
How volatile is Twist Bioscience Corporation stock compared to the marketMaximize your gains with expert trading tips - jammulinksnews.com
Envestnet Asset Management Inc. Has $2.76 Million Position in Twist Bioscience Corporation (NASDAQ:TWST) - Defense World
What institutional investors are buying Twist Bioscience Corporation stockGet professional advice for portfolio optimization - jammulinksnews.com
Twist Bioscience Corporation Stock Analysis and ForecastFree Daily Trading Room Entry - PrintWeekIndia
Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire
Victory Capital Management Inc. Trims Holdings in Twist Bioscience Corporation (NASDAQ:TWST) - Defense World
What drives Twist Bioscience Corporation stock priceFree AI-Backed Trading Signals - jammulinksnews.com
Is Twist Bioscience Corporation a good long term investmentDynamic investment opportunities - Autocar Professional
Bank of New York Mellon Corp Has $21.25 Million Stake in Twist Bioscience Corporation (NASDAQ:TWST) - Defense World
Principal Financial Group Inc. Trims Holdings in Twist Bioscience Corporation (NASDAQ:TWST) - Defense World
Twist Bioscience Corporation (NASDAQ:TWST) Shares Sold by Teacher Retirement System of Texas - Defense World
What makes Twist Bioscience Corporation stock price move sharplyHigh Potential Safe Trades - Newser
How Twist Bioscience Corporation stock performs during market volatilityBreakout Level Watch - Newser
Twist Bioscience to Report Fiscal 2025 Third Quarter Financial Results on Monday, August 4, 2025 - Yahoo Finance
Twist Bioscience Expands Express Delivery Turnaround Time to All Gene Fragments Regardless of Format - Business Wire
Wealth Enhancement Advisory Services LLC Makes New Investment in Twist Bioscience Corporation (NASDAQ:TWST) - Defense World
The Digest’s 2025 Multi-Slide Guide to Twist Bioscience : The Daily Digest - Biofuels Digest
SG Americas Securities LLC Acquires New Holdings in Twist Bioscience Corporation (NASDAQ:TWST) - Defense World
Here's Why We're Not At All Concerned With Twist Bioscience's (NASDAQ:TWST) Cash Burn Situation - Yahoo Finance
Twist Bioscience Co. (NASDAQ:TWST) Shares Purchased by Handelsbanken Fonder AB - Defense World
Twist Bioscience Co. (NASDAQ:TWST) Shares Acquired by GAMMA Investing LLC - Defense World
Rhumbline Advisers Increases Stock Holdings in Twist Bioscience Co. (NASDAQ:TWST) - Defense World
Twist Bioscience Corp (TWST) Shares Up 4.12% on Jun 11 - GuruFocus
Twist Bioscience Executives Sell Shares for Tax Obligations - TradingView
Twist Bioscience Co. (NASDAQ:TWST) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Twist Bioscience Corp (TWST) Stock Price Up 3.86% on Jun 6 - GuruFocus
Twist Bioscience at 45th Annual William Blair Growth Stock Conference: Strategic Advances - Investing.com
Twist Bioscience Corp (TWST) Stock Price Up 5.94% on Jun 2 - GuruFocus
Cetera Investment Advisers Invests $220,000 in Twist Bioscience Co. (NASDAQ:TWST) - Defense World
Investors Don't See Light At End Of Twist Bioscience Corporation's (NASDAQ:TWST) Tunnel And Push Stock Down 25% - simplywall.st
Twist Bioscience Corp (TWST) Shares Gap Down to $28.2 on May 28 - GuruFocus
Twist Bioscience Co. (NASDAQ:TWST) Stake Raised by Nuveen Asset Management LLC - Defense World
Twist Bioscience Co. (NASDAQ:TWST) Shares Sold by Bank of America Corp DE - Defense World
Twist Bioscience Executives Sell Shares to Cover Tax Obligations - TradingView
Ameriprise Financial Inc. Trims Stake in Twist Bioscience Co. (NASDAQ:TWST) - Defense World
Twist Bioscience Corp (TWST) Shares Down 5.14% on May 21 - GuruFocus
Twist Bioscience (TWST) Expands Partnership with Element Bioscie - GuruFocus
Twist Bioscience (TWST) Expands Partnership with Element Biosciences | TWST Stock News - GuruFocus
Twist Bioscience and Element Biosciences Expand Collaboration to Transform Next Generation Sequencing Workflows with Co-Developed End-to-End Solutions - Business Wire
Twist Bioscience stock hits 52-week low at $28.41 By Investing.com - Investing.com Canada
Twist Bioscience stock hits 52-week low at $28.41 - Investing.com
Twist Bioscience Corp Stock (TWST) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):